UK Healthcare Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.

Press releases published on October 1, 2026

Oct. 1, 2026

Healthcare Marketing CEO Steven Lockhart to Launch Men's Telemed and Women's Telemed This Fall

Indeterminate EIN Presswire

Oct. 1, 2026

Neil Lock Launches New Website, Speaking Publicly About Neurodivergence for the First Time

Indeterminate EIN Presswire

Oct. 1, 2026

Consumer Technology And Services Market Report Highlights Key Segments, Regional Trends And Major Competitors

Indeterminate EIN Presswire

Oct. 1, 2026

Analysis of Maternity Support Tank Tops Market Segmentation Highlights Significant Growth Prospects Through 2030

Indeterminate EIN Presswire

Oct. 1, 2026

Clinical Trials Market Report Highlights Key Segments, Regional Trends And Major Competitors

Indeterminate EIN Presswire

Oct. 1, 2026

Global Health Catalyst Names Adriana Sanford Executive Director for Strategic Partnerships & Corporate Engagement

Indeterminate EIN Presswire

Oct. 1, 2026

ancora Software Announces Strong Third Quarter Growth and Continued Healthcare Expansion

Indeterminate EIN Presswire

Oct. 1, 2026

Fuel50 Enters Its Next Chapter as Acquisition by Phoenix Education Partners Closes

Indeterminate EIN Presswire

Oct. 1, 2026

Orifarm unveils 2031 strategy to accelerate growth across Europe, with significant expansion in generics

Indeterminate EIN Presswire

Oct. 1, 2026

PubHive Named Best Life Sciences Workflow SaaS Platform 2026

Indeterminate EIN Presswire

Oct. 1, 2026

ChoiceDx AI Skin Analysis Kiosk Debuts at Torriden Connect Seongsu

Indeterminate EIN Presswire

Oct. 1, 2026

Herman Aesthetiques Launches New Obagi Blue Peels for Skin Rejunevation

Indeterminate EIN Presswire

Oct. 1, 2026

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

Nxera Announces Successful Resolution of miniG Patent Infringement Action

Indeterminate GlobeNewswire

Oct. 1, 2026

DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform

Indeterminate GlobeNewswire

Oct. 1, 2026

Mironid successfully doses initial cohorts in Phase 1 clinical trial investigating the Company’s first-in-class LoAc® small molecule for patients with ADPKD

Indeterminate GlobeNewswire